Clinical Trials · NCT02962492
An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- University at Buffalo
- Enrollment
- 70
- Start date
- Nov 2016
- Locations
- 1 site, United States
- Primary endpoint
- Change in Beta-hydroxybutyrate Levels in Blood